Hey2tm1Eno/Hey2tm2Eno Tg(Nkx2-5-cre)9Eno/0
involves: 129S6/SvEvTac * C57BL/6 * SJL
|
abnormal heart left ventricle morphology |
J:121577
|
abnormal heart ventricle morphology |
J:121577
|
abnormal interventricular septum morphology |
J:121577
|
normal
cardiovascular system phenotype |
J:121577
|
decreased cardiac muscle contractility |
J:121577
|
dilated heart right ventricle |
J:121577
|
enlarged heart |
J:121577
|
Hey2tm1Eno/Hey2tm2Eno Tg(Tagln-cre)1Her/0
involves: 129S6/SvEvTac * C57BL/6 * SJL
|
decreased cardiac muscle contractility |
J:121577
|
dilated heart right ventricle |
J:121577
|
perinatal lethality, incomplete penetrance |
J:121577
|
ventricular septal defect |
J:121577
|
Hey2tm1Eno/Hey2tm2Eno Tg(Tek-cre)1Ywa/0
involves: 129S6/SvEvTac * C57BL/6 * SJL
|
normal
cardiovascular system phenotype |
J:121577
|
normal
mortality/aging |
J:121577
|
Hey2tm1Gess/Hey2tm1Gess
B6.129P2-Hey2tm1Gess
|
abnormal cardiovascular system morphology |
J:93980
|
abnormal heart shape |
J:93980
|
patent cardiac foramen ovale |
J:93980
|
perimembraneous ventricular septal defect |
J:93980
|
postnatal lethality, incomplete penetrance |
J:93980
|
tricuspid valve atresia |
J:93980
|
tricuspid valve stenosis |
J:93980
|
Hey2tm1Gess/Hey2tm1Gess
involves: 129P2/OlaHsd
|
abnormal cardiac epithelial to mesenchymal transition |
J:133699
|
perimembraneous ventricular septal defect |
J:133699
|
Hey2tm1Gess/Hey2tm1Gess
involves: 129P2/OlaHsd * C57BL/6
|
atrial septal defect |
J:79024
|
cardiac fibrosis |
J:79024
|
heart left ventricle hypertrophy |
J:79024
|
heart right ventricle hypertrophy |
J:79024
|
increased heart weight |
J:79024
|
myocardial fiber disarray |
J:79024
|
postnatal growth retardation |
J:79024
|
postnatal lethality, incomplete penetrance |
J:79024
|
ventricular septal defect |
J:79024
|
Hey2tm1Gess/Hey2tm1Gess
involves: 129P2/OlaHsd * CD-1
|
postnatal lethality, incomplete penetrance |
J:93980
|
ventricular septal defect |
J:93980
|
Hey2tm1Kkb/Hey2tm1Kkb
involves: 129S7/SvEvBrd * C57BL/6
|
abnormal aortic valve cusp morphology |
J:97120
|
abnormal atrioventricular valve morphology |
J:97120
|
abnormal endocardium morphology |
J:97120
|
abnormal mitral valve morphology |
J:97120
|
abnormal myocardial fiber morphology |
J:97120,
J:216895
|
abnormal myocardium layer morphology |
J:216895
|
abnormal pulmonary alveolus morphology |
J:97120
|
abnormal pulmonary valve cusp morphology |
J:97120
|
abnormal semilunar valve morphology |
J:97120,
J:216895
|
abnormal tricuspid valve morphology |
J:97120
|
abnormal ventricle myocardium morphology |
J:216895
|
abnormal Z line morphology |
J:216895
|
aortic valve regurgitation |
J:216895
|
aortic valve stenosis |
J:216895
|
atrioventricular valve regurgitation |
J:97120
|
cardiac fibrosis |
J:216895
|
congestive heart failure |
J:97120
|
decreased heart rate |
J:97120
|
decreased ventricle muscle contractility |
J:97120,
J:216895
|
dilated heart atrium |
J:97120
|
dilated heart left ventricle |
J:97120,
J:216895
|
dilated heart right ventricle |
J:97120
|
enlarged heart |
J:97120
|
increased heart weight |
J:97120
|
increased lung weight |
J:97120
|
liver vascular congestion |
J:97120
|
mitral valve regurgitation |
J:97120
|
ostium secundum atrial septal defect |
J:97120
|
perimembraneous ventricular septal defect |
J:97120
|
postnatal growth retardation |
J:97120
|
postnatal lethality, complete penetrance |
J:97120
|
premature death |
J:216895
|
pulmonary edema |
J:97120
|
pulmonary vascular congestion |
J:97120
|
respiratory distress |
J:97120
|
thick aortic valve |
J:216895
|
thick pulmonary valve |
J:216895
|
tricuspid valve regurgitation |
J:97120
|
tricuspid valve stenosis |
J:97120
|
Hey2tm1Mtc/Hey2tm1Mtc
B6.Cg-Hey2tm1Mtc
|
abnormal atrioventricular valve morphology |
J:105823
|
abnormal blood vessel morphology |
J:105823
|
abnormal heart ventricle morphology |
J:105823
|
abnormal pulmonary artery morphology |
J:105823
|
abnormal tricuspid valve morphology |
J:105823
|
decreased aorta wall thickness |
J:105823
|
dilated heart left ventricle |
J:105823
|
lethality at weaning, incomplete penetrance |
J:105823
|
thick mitral valve cusps |
J:105823
|
thin ventricular wall |
J:105823
|
ventricular septal defect |
J:105823
|
Hey2tm1Mtc/Hey2tm1Mtc
C.Cg-Hey2tm1Mtc
|
abnormal atrioventricular valve morphology |
J:105823
|
abnormal heart septum morphology |
J:105823
|
abnormal mitral valve morphology |
J:105823
|
lethality at weaning, incomplete penetrance |
J:105823
|
tricuspid valve atresia |
J:105823
|
tricuspid valve stenosis |
J:105823
|
ventricular septal defect |
J:105823
|
Hey2tm1Mtc/Hey2tm1Mtc
involves: 129X1/SvJ
|
absent interventricular septum membranous part |
J:80681
|
normal
cardiovascular system phenotype |
J:80681
|
liver vascular congestion |
J:80681
|
perimembraneous ventricular septal defect |
J:80681
|
postnatal growth retardation |
J:80681
|
postnatal lethality, complete penetrance |
J:80681
|
pulmonary vascular congestion |
J:80681
|
visceral vascular congestion |
J:80681
|
Hey2tm1Mtc/Hey2tm1Mtc
involves: 129X1/SvJ * C57BL/6
|
absent interventricular septum membranous part |
J:80681
|
cardiac interstitial fibrosis |
J:80681
|
cardiomyopathy |
J:80681
|
decreased body size |
J:80681
|
decreased cardiac muscle contractility |
J:80681
|
liver vascular congestion |
J:80681
|
perimembraneous ventricular septal defect |
J:80681
|
postnatal growth retardation |
J:80681
|
postnatal lethality, incomplete penetrance |
J:80681
|
pulmonary vascular congestion |
J:80681
|
visceral vascular congestion |
J:80681
|
Hey2tm1Uts/Hey2tm1Uts
either: (involves: 129X1/SvJ) or (involves: C57BL/6)
|
abnormal heart development |
J:79025
|
abnormal heart shape |
J:79025
|
abnormal pulmonary valve cusp morphology |
J:79025
|
atrial septal defect |
J:79025
|
enlarged heart |
J:79025
|
heart left ventricle hypertrophy |
J:79025
|
heart right ventricle hypertrophy |
J:79025
|
muscular ventricular septal defect |
J:79025
|
overriding aortic valve |
J:79025
|
perimembraneous ventricular septal defect |
J:79025
|
postnatal lethality, incomplete penetrance |
J:79025
|
pulmonary artery stenosis |
J:79025
|
pulmonary valve stenosis |
J:79025
|
tricuspid valve atresia |
J:79025
|
Hey2tm2.1Mtc/Hey2tm2.1Mtc Tg(Myh6-cre)2182Mds/0
involves: C57BL/6 * FVB/N * SJL
|
abnormal myocardial fiber physiology |
J:186570
|
cardiac fibrosis |
J:186570
|
cardiac hypertrophy |
J:186570
|
congestive heart failure |
J:186570
|
decreased cardiac muscle contractility |
J:186570
|
increased response of heart to induced stress |
J:186570
|
Hey2tm2Eno/Hey2tm2Eno
129-Hey2tm2Eno
|
neonatal lethality, complete penetrance |
J:121577
|
ventricular septal defect |
J:121577
|
Hey2tm2Eno/Hey2tm2Eno
involves: 129S6/SvEvTac * C57BL/6
|
neonatal lethality, complete penetrance |
J:121577
|
ventricular septal defect |
J:121577
|